FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2890722900> ?p ?o ?g. }

• W2890722900 endingPage "e022831" @default.
• W2890722900 startingPage "e022831" @default.
• W2890722900 abstract "Introduction Gestational diabetes increases maternal and offspring complications in pregnancy and cardiovascular complications in the long term. The nutritional supplement myo -inositol may prevent gestational diabetes; however, further evaluation is required, especially in multiethnic high-risk mothers. Our pilot trial on myo -inositol to prevent gestational diabetes will evaluate trial processes, assess acceptability to mothers and obtain preliminary estimates of effect and cost data prior to a large full-scale trial. Methods and analysis EMmY is a multicentre, placebo-controlled, double-blind, pilot, randomised trial, with qualitative evaluation. We will recruit pregnant women at 12–15 +6 weeks’ gestation, with gestational diabetes risk factors, from five maternity units in England between 2018 and 2019. We will randomise 200 women to take either 2 g of myo -inositol powder (intervention) or placebo, twice daily until delivery. We will assess rates of recruitment, randomisation, adherence to intervention and follow-up. Gestational diabetes will be diagnosed at 24–28 weeks as per the National Institute for Health and Care Excellence (NICE) criteria (fasting plasma glucose: ≥5.6 mmol/L and 2-hour plasma glucose: ≥7.8 mmol/L). We will assess the effects of myo -inositol on glycaemic indices at 28 weeks and on other maternal, fetal and neonatal outcomes at postnatal discharge. Qualitative evaluation will explore the acceptability of the trial and the intervention among women and healthcare professionals. Cost data and health-related quality of life measures will be captured. We will summarise feasibility outcomes using standard methods for proportions and other descriptive statistics, and where appropriate, report point estimates of effect sizes (eg, mean differences and relative risks) and associated 95% CIs. Ethics and dissemination Ethical approval was obtained through the London Queen Square Research Ethics Committee (17/LO/1741). Study findings will be submitted for publication in peer-reviewed journals. Newsletters will be made available to participants, healthcare professionals and members of Katie’s Team (a patient and public advisory group) to disseminate. Trial registration number ISRCTN48872100. Protocol version and date Version 4.0, 15 January 2018." @default.
• W2890722900 created "2018-09-27" @default.
• W2890722900 creator A5016156410 @default.
• W2890722900 creator A5016623962 @default.
• W2890722900 creator A5025610333 @default.
• W2890722900 creator A5028099145 @default.
• W2890722900 creator A5035453252 @default.
• W2890722900 creator A5039259985 @default.
• W2890722900 creator A5045203195 @default.
• W2890722900 creator A5046598885 @default.
• W2890722900 creator A5064649684 @default.
• W2890722900 creator A5064959070 @default.
• W2890722900 creator A5067493767 @default.
• W2890722900 creator A5074361466 @default.
• W2890722900 creator A5085995898 @default.
• W2890722900 creator A5086877004 @default.
• W2890722900 creator A5088639578 @default.
• W2890722900 creator A5088930027 @default.
• W2890722900 date "2018-09-01" @default.
• W2890722900 modified "2023-09-22" @default.
• W2890722900 title "Effectiveness and acceptability of<i>myo</i>-inositol nutritional supplement in the prevention of gestational diabetes (EMmY): a protocol for a randomised, placebo-controlled, double-blind pilot trial" @default.
• W2890722900 cites W1524829680 @default.
• W2890722900 cites W1972251954 @default.
• W2890722900 cites W2010698464 @default.
• W2890722900 cites W2021720741 @default.
• W2890722900 cites W2024190973 @default.
• W2890722900 cites W2041600174 @default.
• W2890722900 cites W2065426514 @default.
• W2890722900 cites W2100551231 @default.
• W2890722900 cites W2115844812 @default.
• W2890722900 cites W2136132888 @default.
• W2890722900 cites W2144209205 @default.
• W2890722900 cites W2155326729 @default.
• W2890722900 cites W2158497651 @default.
• W2890722900 cites W2162544110 @default.
• W2890722900 cites W2227264641 @default.
• W2890722900 cites W2309207579 @default.
• W2890722900 cites W2400418856 @default.
• W2890722900 cites W2553327367 @default.
• W2890722900 cites W2560666190 @default.
• W2890722900 cites W2661816524 @default.
• W2890722900 doi "https://doi.org/10.1136/bmjopen-2018-022831" @default.
• W2890722900 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6157508" @default.
• W2890722900 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30249632" @default.
• W2890722900 hasPublicationYear "2018" @default.
• W2890722900 type Work @default.
• W2890722900 sameAs 2890722900 @default.
• W2890722900 citedByCount "5" @default.
• W2890722900 countsByYear W28907229002020 @default.
• W2890722900 countsByYear W28907229002022 @default.
• W2890722900 countsByYear W28907229002023 @default.
• W2890722900 crossrefType "journal-article" @default.
• W2890722900 hasAuthorship W2890722900A5016156410 @default.
• W2890722900 hasAuthorship W2890722900A5016623962 @default.
• W2890722900 hasAuthorship W2890722900A5025610333 @default.
• W2890722900 hasAuthorship W2890722900A5028099145 @default.
• W2890722900 hasAuthorship W2890722900A5035453252 @default.
• W2890722900 hasAuthorship W2890722900A5039259985 @default.
• W2890722900 hasAuthorship W2890722900A5045203195 @default.
• W2890722900 hasAuthorship W2890722900A5046598885 @default.
• W2890722900 hasAuthorship W2890722900A5064649684 @default.
• W2890722900 hasAuthorship W2890722900A5064959070 @default.
• W2890722900 hasAuthorship W2890722900A5067493767 @default.
• W2890722900 hasAuthorship W2890722900A5074361466 @default.
• W2890722900 hasAuthorship W2890722900A5085995898 @default.
• W2890722900 hasAuthorship W2890722900A5086877004 @default.
• W2890722900 hasAuthorship W2890722900A5088639578 @default.
• W2890722900 hasAuthorship W2890722900A5088930027 @default.
• W2890722900 hasBestOaLocation W28907229001 @default.
• W2890722900 hasConcept C126322002 @default.
• W2890722900 hasConcept C131872663 @default.
• W2890722900 hasConcept C134018914 @default.
• W2890722900 hasConcept C142724271 @default.
• W2890722900 hasConcept C168563851 @default.
• W2890722900 hasConcept C1862650 @default.
• W2890722900 hasConcept C187212893 @default.
• W2890722900 hasConcept C204787440 @default.
• W2890722900 hasConcept C27081682 @default.
• W2890722900 hasConcept C2775887326 @default.
• W2890722900 hasConcept C2778376644 @default.
• W2890722900 hasConcept C2779234561 @default.
• W2890722900 hasConcept C2779434492 @default.
• W2890722900 hasConcept C2908647359 @default.
• W2890722900 hasConcept C46973012 @default.
• W2890722900 hasConcept C54355233 @default.
• W2890722900 hasConcept C555293320 @default.
• W2890722900 hasConcept C71924100 @default.
• W2890722900 hasConcept C86803240 @default.
• W2890722900 hasConcept C99454951 @default.
• W2890722900 hasConceptScore W2890722900C126322002 @default.
• W2890722900 hasConceptScore W2890722900C131872663 @default.
• W2890722900 hasConceptScore W2890722900C134018914 @default.
• W2890722900 hasConceptScore W2890722900C142724271 @default.
• W2890722900 hasConceptScore W2890722900C168563851 @default.
• W2890722900 hasConceptScore W2890722900C1862650 @default.
• W2890722900 hasConceptScore W2890722900C187212893 @default.
• W2890722900 hasConceptScore W2890722900C204787440 @default.
• W2890722900 hasConceptScore W2890722900C27081682 @default.

• next